Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126646632 | 12664663 | 2 | F | 20160919 | 20160818 | 20160928 | EXP | JP-TEVA-685815ISR | TEVA | SAMESHIMA S,KOKETSU S,OKUYAMA T,KUBOTA Y,ONO Y,NOIE T. | 17.00 | YR | M | Y | 0.00000 | 20160928 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126646632 | 12664663 | 1 | PS | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | 35 MILLIGRAM DAILY; | Y | 89081 | |||||||||
| 126646632 | 12664663 | 2 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | 12.5 MILLIGRAM DAILY; | Y | 89081 | |||||||||
| 126646632 | 12664663 | 3 | SS | CICLOSPORIN | CYCLOSPORINE | 1 | Unknown | 250 MILLIGRAM DAILY; | U | 65078 | |||||||||
| 126646632 | 12664663 | 4 | SS | MESALAZINE | MESALAMINE | 1 | Unknown | 2250 MILLIGRAM DAILY; | U | 0 | |||||||||
| 126646632 | 12664663 | 5 | SS | MIZORIBINE | MIZORIBINE | 1 | Unknown | 150 MILLIGRAM DAILY; | U | 0 | |||||||||
| 126646632 | 12664663 | 6 | SS | Panitumumab | PANITUMUMAB | 1 | Unknown | D | 0 | ||||||||||
| 126646632 | 12664663 | 7 | SS | Folinic acid | LEUCOVORIN | 1 | Unknown | D | Y | 0 | |||||||||
| 126646632 | 12664663 | 8 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Unknown | D | Y | 0 | |||||||||
| 126646632 | 12664663 | 9 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Unknown | D | Y | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126646632 | 12664663 | 1 | Nephrotic syndrome |
| 126646632 | 12664663 | 3 | Nephrotic syndrome |
| 126646632 | 12664663 | 4 | Colitis ulcerative |
| 126646632 | 12664663 | 5 | Nephrotic syndrome |
| 126646632 | 12664663 | 6 | Rectal cancer |
| 126646632 | 12664663 | 7 | Rectal cancer |
| 126646632 | 12664663 | 8 | Rectal cancer |
| 126646632 | 12664663 | 9 | Rectal cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126646632 | 12664663 | HO |
| 126646632 | 12664663 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126646632 | 12664663 | Nephrotic syndrome | Nephrotic syndrome |
| 126646632 | 12664663 | Neuropathy peripheral | Neuropathy peripheral |
| 126646632 | 12664663 | Rash | Rash |
| 126646632 | 12664663 | Rectal cancer | Rectal cancer |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126646632 | 12664663 | 4 | 2000 | 0 |